0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query globaldata pharmapoint crohn s disease global drug forecast market analysis 2022.Your search for "" gave back 1533059 results.
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2018 Summary Intercellular Adhesion...
Catalog:
Global Markets Direct
January 2018
Price: USD 3,500.00
Colitis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis -...
Catalog:
Global Markets Direct
September 2019
Price: USD 2,000.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019 Summary Integrin Alpha 4 (...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H2 2018 Summary Intercellular Adhesion...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
Colitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis -...
Catalog:
Global Markets Direct
July 2018
Price: USD 2,000.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Prevalence of Crohn’s disease has increased in developing countries owing to industrialization, environmental factors such as differences in exposure...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Cimzia (certolizumab) Drug is a biologic medication that belongs to the class of drugs known as TNF-alpha inhibitors. It is used to treat a variety...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
